Inhibitory Effects of Dimeric Copper(II) Bis(o-Acetoxybenzoate) on Platelet-neutrophil Adhesion and Thrombosis
2001

Effects of Copper-Aspirin Complex on Blood Clotting

Sample size: 50 publication 10 minutes Evidence: moderate

Author Information

Author(s): Zhiqiang Shen, Lanou Wu, Weiping Liu, Jikai Liu, Zhihhe Chen

Primary Institution: Yunnan Pharmacological Laboratories of Natural Products, Kunming Medical College

Hypothesis

Does the copper-aspirin complex inhibit platelet-neutrophil adhesion and thrombosis?

Conclusion

The copper-aspirin complex significantly reduces blood clot formation and platelet-neutrophil adhesion.

Supporting Evidence

  • The copper-aspirin complex reduced wet thrombus weight significantly compared to the saline group.
  • It showed a dose-dependent inhibition of platelet-neutrophil adhesion.
  • The IC50 value for the copper-aspirin complex was 41.5 µmol L-1.

Takeaway

This study found that a special copper-aspirin medicine can help prevent blood clots by stopping certain blood cells from sticking together.

Methodology

Male Sprague Dawley rats were used to test the effects of the copper-aspirin complex on thrombosis and platelet-neutrophil adhesion.

Limitations

The study was conducted only on rats, which may not fully represent human responses.

Participant Demographics

Male Sprague Dawley rats weighing 200-250 g.

Statistical Information

P-Value

p<0.01

Statistical Significance

p<0.01

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication